Key points are not available for this paper at this time.
Journal Article Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within Groups Get access J. B. Robbins, J. B. Robbins Search for other works by this author on: Oxford Academic PubMed Google Scholar R. Austrian, R. Austrian Search for other works by this author on: Oxford Academic PubMed Google Scholar C.-J. Lee, C.-J. Lee Search for other works by this author on: Oxford Academic PubMed Google Scholar S. C. Rastogi, S. C. Rastogi Search for other works by this author on: Oxford Academic PubMed Google Scholar G. Schiffman, G. Schiffman Search for other works by this author on: Oxford Academic PubMed Google Scholar J. Henrichsen, J. Henrichsen Search for other works by this author on: Oxford Academic PubMed Google Scholar P. H. Makela, P. H. Makela Search for other works by this author on: Oxford Academic PubMed Google Scholar C. V. Broome, C. V. Broome Search for other works by this author on: Oxford Academic PubMed Google Scholar R. R. Facklam, R. R. Facklam Search for other works by this author on: Oxford Academic PubMed Google Scholar R. H. Tiesjema, R. H. Tiesjema Search for other works by this author on: Oxford Academic PubMed Google Scholar ... Show more J. C. Parke, Jr J. C. Parke, Jr Search for other works by this author on: Oxford Academic PubMed Google Scholar The Journal of Infectious Diseases, Volume 148, Issue 6, December 1983, Pages 1136–1159, https://doi.org/10.1093/infdis/148.6.1136 Published: 01 December 1983
Robbins et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: